Spectral AI Completes Proof of Concept for Wound Measurement Technology

DALLAS, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced the completion of a proof-of-concept module of its wound measurement technology that calculates the total body surface area (“TBSA”) of a burn. This technology, which is currently integrated into the Company’s DeepView^® System for burn indication (“DeepView AI^®-Burn”), provides a fast, accurate, and standardized measurement that the Company believes is a significant improvement over current wound size measurement technology and can improve patient treatment decisions.